7-83367765-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012431.3(SEMA3E):​c.2149A>G​(p.Ile717Val) variant causes a missense change. The variant allele was found at a frequency of 0.00452 in 1,614,052 control chromosomes in the GnomAD database, including 311 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I717M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.024 ( 138 hom., cov: 32)
Exomes 𝑓: 0.0025 ( 173 hom. )

Consequence

SEMA3E
NM_012431.3 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.69

Publications

2 publications found
Variant links:
Genes affected
SEMA3E (HGNC:10727): (semaphorin 3E) Semaphorins are a large family of conserved secreted and membrane associated proteins which possess a semaphorin (Sema) domain and a PSI domain (found in plexins, semaphorins and integrins) in the N-terminal extracellular portion. Based on sequence and structural similarities, semaphorins are put into eight classes: invertebrates contain classes 1 and 2, viruses have class V, and vertebrates contain classes 3-7. Semaphorins serve as axon guidance ligands via multimeric receptor complexes, some (if not all) containing plexin proteins. This gene encodes a class 4 semaphorin. This gene encodes a class 3 semaphorin. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
SEMA3E Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • Kallmann syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • CHARGE syndrome
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038186014).
BP6
Variant 7-83367765-T-C is Benign according to our data. Variant chr7-83367765-T-C is described in ClinVar as Benign. ClinVar VariationId is 459537.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0812 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SEMA3ENM_012431.3 linkc.2149A>G p.Ile717Val missense_variant Exon 17 of 17 ENST00000643230.2 NP_036563.1
SEMA3ENM_001178129.2 linkc.1969A>G p.Ile657Val missense_variant Exon 17 of 17 NP_001171600.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SEMA3EENST00000643230.2 linkc.2149A>G p.Ile717Val missense_variant Exon 17 of 17 NM_012431.3 ENSP00000496491.1
SEMA3EENST00000643441.1 linkn.2134A>G non_coding_transcript_exon_variant Exon 17 of 17

Frequencies

GnomAD3 genomes
AF:
0.0238
AC:
3619
AN:
152056
Hom.:
135
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0834
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00780
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.0105
GnomAD2 exomes
AF:
0.00599
AC:
1507
AN:
251482
AF XY:
0.00443
show subpopulations
Gnomad AFR exome
AF:
0.0844
Gnomad AMR exome
AF:
0.00278
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00250
AC:
3661
AN:
1461878
Hom.:
173
Cov.:
32
AF XY:
0.00215
AC XY:
1561
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.0895
AC:
2996
AN:
33480
American (AMR)
AF:
0.00398
AC:
178
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000185
AC:
16
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00347
AC:
20
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000603
AC:
67
AN:
1111998
Other (OTH)
AF:
0.00636
AC:
384
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
214
428
641
855
1069
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0239
AC:
3636
AN:
152174
Hom.:
138
Cov.:
32
AF XY:
0.0235
AC XY:
1746
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.0836
AC:
3469
AN:
41520
American (AMR)
AF:
0.00779
AC:
119
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.000623
AC:
3
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000323
AC:
22
AN:
68014
Other (OTH)
AF:
0.0104
AC:
22
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
164
327
491
654
818
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00849
Hom.:
98
Bravo
AF:
0.0264
ESP6500AA
AF:
0.0817
AC:
360
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00745
AC:
904
Asia WGS
AF:
0.00982
AC:
34
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 23, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

CHARGE syndrome Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.057
T;T;.
Eigen
Benign
0.17
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.72
.;T;T
MetaRNN
Benign
0.0038
T;T;T
MetaSVM
Benign
-0.82
T
MutationAssessor
Benign
1.8
L;L;.
PhyloP100
4.7
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.39
N;.;N
REVEL
Uncertain
0.35
Sift
Benign
0.54
T;.;T
Sift4G
Benign
0.43
T;.;T
Polyphen
0.41
B;B;.
Vest4
0.21
MVP
0.76
MPC
0.31
ClinPred
0.012
T
GERP RS
5.7
Varity_R
0.11
gMVP
0.25
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61729610; hg19: chr7-82997081; COSMIC: COSV107331308; COSMIC: COSV107331308; API